Multiple pituitary hormones

The phrase “multiple pituitary hormones” refers broadly to several distinct peptide/protein/glycoprotein signaling molecules secreted by the anterior and posterior lobes of the human pituitary gland, also known as the master gland due to its central regulatory role over other endocrine organs. These include adrenocorticotropic hormone (ACTH), thyroid-stimulating hormone (TSH), luteinizing hormone (LH), follicle-stimulating hormone (FSH), prolactin (PRL), growth hormone (GH), melanocyte-stimulating-hormone(s) from intermediate lobe cells, antidiuretic-hormone/vasopressin and oxytocin from posterior lobe storage/release sites. Each exerts unique effects via dedicated receptors throughout peripheral tissues—regulation includes feedback loops involving hypothalamic releasing/inhibiting factors—and dysregulation leads to diverse clinical syndromes depending on which axis/hormones are affected[1][4][6]. \n\nIn summary: “Multiple pituitary hormones” should not be treated as a single molecular entity but instead parsed into their well-defined components for any structured biomedical application.

Varies by drug/hormone axis—includes receptor agonism/antagonism at downstream endocrine glands or direct replacement therapy.